Inter Pharma Share Price

IP

TH9474010005

Pharmaceuticals

End-of-day quote Thailand S.E. 25/08/2026			5-day change	1st Jan Change
5.050 ^THB	+1.41%		-6.48%	+9.78%

14/08	Inter Pharma Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
11/05	Inter Pharma Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Interpharma Public Company Limited is a Thailand-based company that develops, researches and distributes healthcare products and beauty initiatives for human beings, and healthcare products for animals. The Company provides wellness and anti-aging products, aesthetic innovation products, companion animal health products and livestock products. Its products include PREBO, YUUU toothpaste, multivitamin, Probac 7, Probac 10, Beta Glucan Plus, Pure Krill Oil, Astacurmin, YUUU cleansing mousse, Perfectha Complement, Perfectha Derm, Perfectha Deep, Perfectha Subskin and Uderma.

Employees

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
25/26/25	THB 5.050	+1.41%	61,892
24/26/24	THB 4.980	-2.35%	2,66,901
21/26/21	THB 5.100	-0.97%	54,306
20/26/20	THB 5.150	+0.98%	1,62,318
19/26/19	THB 5.100	-5.56%	9,30,363

End-of-day quote Thailand S.E.

More quotes

Annual profits - Rate of surprise

Company calendar

Market Cap	305.7Cr 9.34Cr 8Cr 7.5Cr 6.85Cr 13Cr 890.26Cr 13Cr 88Cr 34Cr 449.16Cr 35Cr 34Cr 1.49TCr	P/E 2024	52.3x	P/E 2025	22.8x
Enterprise Value	317.63Cr 9.7Cr 8.31Cr 7.79Cr 7.12Cr 13Cr 925Cr 14Cr 92Cr 36Cr 466.69Cr 36Cr 36Cr 1.55TCr	EV / Sales 2024	1.13x	EV / Sales 2025	1.31x
Free-Float	-	Yield 2024 *	-	Yield 2025	1.59%

14/08	Inter Pharma Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
11/05	Inter Pharma Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
02/03	Inter Pharma Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2025	CI
02/03	Inter Pharma Public Company Limited announces Annual dividend, payable on May 25, 2026	CI
12/11	Inter Pharma Public Company Limited (SET:IP) agreed to acquire an additional 49% stake in Interpharma- ZEAvita Company Limited from Thai Union Ingredients.	CI
12/11	Inter Pharma Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
14/25/14	Inter Pharma Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
13/25/13	Inter Pharma Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
16/25/16	Zhaoke Ophthalmology, Interpharma Strike Thailand Drug Distribution Deal	MT
16/25/16	Zhaoke Ophthalmology Limited Enters into Three Distribution and Supply Agreements with Interpharma Public Company Limited	CI
01/25/01	Inter Pharma Public Company Limited Signs Exclusive Distribution Agreement with Zhaoke Ophthalmology Company Limited for Comprehensive Eye Care Innovation	CI
25/25/25	Inter Pharma Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2024	CI
25/25/25	Inter Pharma Public Company Limited Proposes to Omit Dividend Payment for the Year Ended December 31, 2024	CI

17/22/17	Inter Pharma : New shares of IP to be traded on August 18, 2022	PU
10/22/10	Inter Pharma Public : Notification on Change of Directors and Authorization of Directors	PU
10/22/10	Inter Pharma Public : Report on the results of sale of common shares offered to private placement (F53-5)	PU
10/22/10	Inter Pharma Public : Right Adjustment of IP-W1 (Edited)	PU
10/22/10	Inter Pharma Public : Right Adjustment of IP-W1	PU

1 day	+1.41%
1 week	-6.48%
Current month	-4.72%
1 month	-6.48%
3 months	+21.39%
6 months	+17.44%
Current year	+9.78%

1 week	4.96	5.3
1 month	4.96	5.65
Current year	3.68	5.65
1 year	3.14	5.65
3 years	2.02	7.3
5 years	2.02	14.46
10 years	1.62	15.14

Inter Pharma Share Price

Stocks

IP

TH9474010005

Pharmaceuticals

Valuation: Inter Pharma

Chart: Inter Pharma

Latest news : Inter Pharma

Press Releases: Inter Pharma

Quotes and Performance

Course Extremes

Managers and Directors: Inter Pharma

Latest insider transactions

Other Pharmaceuticals

Financials

Company Profile

Quotes

Annual profits - Rate of surprise

Manager	Title	Age	Since
Trinnawat Thanitnithiphan CEO	Chief Executive Officer	56	01/02/2014
Chatkaew Krudkosol DFI	Director of Finance/CFO	56	23/06/2023
Chompunuch Meevang CMP	Compliance Officer	54	-

Director	Title	Age	Since
Napaporn Dechakarat BRD	Director/Board Member	51	14/06/2017
Sansanee Chaiyaroj BRD	Director/Board Member	64	01/08/2020
Trinnawat Thanitnithiphan BRD	Director/Board Member	56	01/02/2014

Date	Insider	Type	Main position	Quantity	% Market Cap.
03/10/25	Trinnawat Thanitnithiphan	Buy	Chief Executive Officer	1,00,000	0.0165%
17/01/25	Trinnawat Thanitnithiphan	Buy	Chief Executive Officer	1,00,000	0.0165%
10/01/25	Trinnawat Thanitnithiphan	Buy	Chief Executive Officer	20,000	0.0033%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
INTER PHARMA	+1.41%	-6.48%	+50.30%	-18.75%	9.34Cr
ELI LILLY AND COMPANY	-1.06%	+0.65%	+77.42%	+122.82%	1,10000Cr
JOHNSON & JOHNSON	+0.53%	+0.75%	+53.10%	+64.29%	66TCr
ABBVIE INC.	+0.48%	+2.65%	+28.06%	+81.19%	47TCr
ROCHE HOLDING AG	+0.92%	+3.57%	+43.82%	+44.21%	37TCr
NOVARTIS AG	+1.25%	+2.21%	+26.77%	+43.05%	30TCr
ASTRAZENECA PLC	+3.02%	+5.68%	+4.24%	+17.04%	26TCr
AMGEN INC.	-0.36%	+3.99%	+53.31%	+72.49%	24TCr
NOVO NORDISK A/S	+2.86%	+3.86%	-16.20%	-51.83%	21TCr
GILEAD SCIENCES, INC.	+1.38%	+3.72%	+30.33%	+93.56%	18TCr
Average	+1.04%	+2.61%	+35.11%	+46.81%	38.03TCr
Weighted average by Cap.	+0.45%	+2.21%	+45.68%	+71.81%

	2024	2025
Net sales	191.19Cr 5.84Cr 5Cr 4.69Cr 4.28Cr 8.08Cr 556.8Cr 8.16Cr 55Cr 22Cr 280.92Cr 22Cr 21Cr 930.31Cr	221.41Cr 6.76Cr 5.8Cr 5.43Cr 4.96Cr 9.36Cr 644.78Cr 9.45Cr 64Cr 25Cr 325.31Cr 25Cr 25Cr 1.08TCr
Net income	3.73Cr 11.39L 10L 9L 8L 15.76L 11Cr 15.92L 1.08Cr 41.99L 5.48Cr 42.76L 41.83L 18Cr	12Cr 37.38L 32.03L 30.02L 27.42L 51.74L 36Cr 52.26L 3.54Cr 1.38Cr 18Cr 1.4Cr 1.37Cr 60Cr
Net Debt	21Cr 63.82L 54.69L 51.24L 46.81L 88.33L 61Cr 89.21L 6.04Cr 2.35Cr 31Cr 2.4Cr 2.34Cr 101.65Cr	12Cr 36.44L 31.23L 29.26L 26.73L 50.44L 35Cr 50.94L 3.45Cr 1.34Cr 18Cr 1.37Cr 1.34Cr 58Cr